Järeiden puutuotteiden erikoiskuivaus

Tutkimuksessa selvitettiin kuumakuivauksen vaikutusta hirsiraaka-aineen ominaisuuksiin, käyttökelpoisia kuivauskaavoja sekä lämpötilatasoja. Kokeissa kuivattiin kuorittuja pyöreitä mäntytukkeja 130-180° C:n maksimilämpötilassa, sekä pelkaksi sahattuja hirsiaihioita 115-140° C:n maksimilämpötilassa. Kuivauksissa pyrittiin mahdollisimman lyhyeen aikaan laadun siitä kuitenkaan kärsimättä. Laadussa kiinnitettiin erityisesti huomiota sisä- ja pintahalkeamiin sekä värimuutoksiin. Korkeita lämpötiloja käytettäessä kuivausaika oli huomattavasti nopeampi kuin lämminilmakuivauksessa. Koekuivaukset kestivät 1-4 vuorokautta, kun vastaavaa puutavaraan lämminilmakuivaus kestää 7-20 vuorokautta. Korkeimmilla lämpötiloilla suoritetuissa kokeissa koekappaleisiin muodostui paljon pieniä halkeamia kun taas alhaisemmilla lämpötiloilla halkeamien kappalemäärä väheni, mutta lähes joka kappaleessa oli vähintään yksi suuri (yli 5 mm leveä) halkeama. Sisähalkeamien määrä oli pyöreillä tukeilla suoritetuissa kokeissa kohtuullisen pieni. Pelkaksi sahatuilla aihioilla sitä vastoin sisähalkeamien määrä oli huomattavasti suurempi. Vain 100 mm x 175 mm aihioilla onnistuttiin yhdessä kuivauksessa pitämään sisähalkeaminen pienenä. Kuumakuivaus aiheuttaa väistämättä värimuutoksia puuhun. Mitä korkeammilla lämpötiloilla ja pidemmillä kaavoilla kuivataan sitä enemmän väri tummenee. Värin vaikutus lopputuotteessa riippuu kuitenkin käyttökohteesta ja asiakkaan mieltymyksistä. Tutkimuksen perusteella varsinkin pyöreiden tukkien kuumakuivaus näyttää onnistuvan laadul-lisesti hyvin ja huomattavasti lämminilmakuivausta nopeammin. Pelkaksi sahattujen hirsiaihioiden kuivauksessa prosessin hallinta havaittiin vaikeaksi ja toimivien kaavojen kehittäminen vaatii jatkotutkimuksia.

Application of morphometry, static DNA ploidy analysis, and steroid receptor expression in diagnosis and prognosis of Libyan breast cancer

The aim of this study was to describe the demographic, clinicopathological, biological and morphometric features of Libyan breast cancer patients. The supporting value of nuclear morphometry and static image cytometry in the sensitivity for detecting breast cancer in conventional fine-needle aspiration biopsies were estimated. The findings were compared with findings in breast cancer in Finland and Nigeria. In addation, the value of ER and PR were evaluated. There were 131 histological samples, 41 cytological samples, and demographic and clinicopathological data from 234 Libyan patients. The Libyan breast cancer is dominantly premenopausal and in this feature it is similar to breast cancer in sub-Saharan Africans, but clearly different from breast cancer in Europeans, whose cancers are dominantly postmenopausal in character. At presention most Libyan patients have locally advanced disease, which is associated with poor survival rates. Nuclear morphometry and image DNA cytometry agree with earlier published data in the Finnish population and indicate that nuclear size and DNA analysis of nuclear content can be used to increase the cytological sensitivity and specificity in doubtful breast lesions, particularly when free cell sampling method is used. Combination of the morphometric data with earlier free cell data gave the following diagnostic guidelines: Range of overlap in free cell samples: 55 μm2 -71 μm2. Cut-off values for diagnostic purposes: Mean nuclear area (MNA) >54 μm2 for 100% detection of malignant cases (specificity 84 %), MNA < 72 μm2 for 100% detection of benign cases (sensitivity 91%). Histomorphometry showed a significant correlation between the MNA and most clinicopathological features, with the strongest association observed for histological grade (p <0.0001). MNA seems to be a prognosticator in Libyan breast cancer (Pearson’s test r = - 0.29, p = 0.019), but at lower level of significance than in the European material. A corresponding relationship was not found in shape-related morphometric features. ER and PR staining scores were in correlation with the clinical stage (p= 0.017, and 0.015, respectively), and also associated with lymph node negative patients (p=0.03, p=0.05, respectively). Receptor-positive (HR+) patients had a better survival. The fraction of HR+ cases among Libyan breast cancers is about the same as the fraction of positive cases in European breast cancer. The study suggests that also weak staining (corresponding to as few as 1% positive cells) has prognostic value. The prognostic significance may be associated with the practice to use antihormonal therapy in HR+ cases. The low survival and advanced presentation is associated with active cell proliferation, atypical nuclear morphology and aneuploid nuclear DNA content in Libyan breast cancer patients. The findings support the idea that breast cancer is not one type of disease, but should probably be classified into premenopausal and post menopausal types.

Role of fibroblast growth factors and their receptors in prostate cancer

Prostate cancer (PCa) is the most common non-cutaneous malignant disease among males in the developed countries. Radical prostatectomy (RP) is an effective therapy for most PCa patients with localized or locally invaded tumors but in some cases the cancer recurs after RP. PCa is a heterogeneous disease, which is regulated by many factors, such as androgen receptor (AR), estrogen receptors and  (ER and ER), fibroblast growth factors (FGFs) and their receptors (FGFRs). In this study, the role of ERβ, FGF8, FGF13 and FGFRL1 was investigated in PCa. Previous studies have suggested that ER is protective against PCa whereas FGF8 has been shown to induce PCa in transgenic mice. FGF13 and FGFRL1 are poorly understood members of the FGF and FGFR families, respectively. Transgenic mouse models were used to investigate the ability of inactivated ERβ to facilitate FGF8-induced prostate tumorigenesis. Human PCa tissue microarrays (TMAs) were used to study the expression pattern of FGF13 and FGFRL1 in PCa and the results were correlated to corresponding patient data. The targets and biological functions of FGF13 and FGFRL1 were characterized using experimental in vivo and in vitro models. The results show that deficiency of ERβ, which had been expected to have tumor suppressing capacity, seemed to influence epithelial differentiation but did not affect FGF8-induced prostate tumorigenesis. Analysis of the TMAs showed increased expression of FGF13 in PCa. The level of cytoplasmic FGF13 was associated with the PCa biochemical recurrence (BCR), demonstrated by increasing serum PSA value, and was able to act as an independent prognostic biomarker for PCa patients after RP. Expression of FGFRL1, the most recently identified FGFR, was also elevated in PCa. Cytoplasmic and nuclear FGFRL1 was associated with high Gleason score and Ki67 level whereas the opposite was true for the cell membrane FGFRL1. Silencing of FGFRL1 in PC-3M cells led to a strongly decreased growth rate of these cells as xenografts in nude mice and the experiments with PCa cell lines showed that FGFRL1 is able to modulate the FGF2- and FGF8-induced signaling pathways. The next generation sequencing (NGS) experiments with FGFRL1-silenced PC-3M cells revealed candidates for FGFRL1 target genes. In summary, these studies provide new data on the FGF/FGFR signaling pathways in normal and malignant prostate and suggest a potential role for FGF13 and FGFRL1 as novel prognostic markers for PCa patients. Keywords: FGF8, FGF13, FGFRL1, ERβ, prostate cancer, prognostic marker